NSE filing, NSE: AJOONI. Summary written from the filing by ALFA Finder's alert engine.
Ajooni Biotech Ltd: key numbers
- Share price
- ₹2.94
- Market cap
- ₹50.64 Cr
- Revenue (annual)
- ₹182.4 Cr
- Net profit (annual)
- ₹4.32 Cr
- P/E (TTM)
- 12.8×Sector 26.2×
- Promoter holding
- 30.53%+3.64% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ajooni Biotech Ltd
All →Ajooni Biotech Other Announcement
Ajooni Biotech informed NSE that its website is updated and functional per Reg 46 of SEBI LODR. This is a routine compliance intimation with no business or financial substance.
Ajooni Biotech Q1 FY27 Results: Net Profit ₹0.4 Cr, Down 50.0% YoY
Ajooni Biotech Ltd reported revenue from operations of ₹63.5 Cr (+102.9% YoY) and net profit of ₹0.4 Cr (-50.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.4 Cr · -50.0% YoY
Ajooni Biotech Capital Structure Change
Ajooni Biotech has allotted 90 lakh equity shares to Healthy Biosciences Limited. The total issue value is ₹3.87 Crore.
- Value
- ₹3.87 Cr
Ajooni Biotech Board Meeting Date
Ajooni Biotech Limited has scheduled a board meeting for August 14, 2026. The board will consider and approve unaudited standalone financial results for the June 2026 quarter.
Ajooni Biotech Capital Structure Change
The company's shareholders approved an increase in its authorized share capital to ₹70 Crore at the 16th Annual General Meeting.
Ajooni Biotech Capital Structure Change
Ajooni Biotech received shareholder approval for the preferential issuance of 90,00,000 equity shares at Rs. 4.30 each, valued at approximately ₹3.87 Crore.
- Value
- ₹3.87 Cr
Other capital structure change announcements
All →Emkay Global Financial Services Capital Structure Change
Emkay Global will invest ₹30.00 Crore in cash in wholly owned subsidiary Emkay Capital. The related-party deal completes within 90 days.
- Value
- ₹30.00 Cr
- Execution
- Within 90 days
OnEMI Technology Solutions Capital Structure Change
OnEMI will invest ₹624.15 Crore in its wholly owned subsidiary Si Creva via rights subscription. Funds come from preferential issue proceeds, completing by December 2026.
- Value
- ₹624.1 Cr
- Execution
- By end of December 2026
Meesho Capital Structure Change
Meesho approved up to Rs.400 Crore capital infusion into its wholly owned subsidiary, Meesho Payments. Board also approved a new subsidiary and further Kirana Club investments.
- Value
- ₹400.0 Cr
Womancart Capital Structure Change
Womancart Limited submitted its draft letter of offer for a rights issue of up to Rs.1,200 lakhs to eligible shareholders. The issue is pending in-principle approval from NSE Emerge, with the price, ratio and dates still blank.
- Value
- ₹12.00 Cr
Hero MotoCorp Capital Structure Change
Hero MotoCorp's board approved up to ₹300 Crore additional investment in wholly-owned subsidiary HMCL Netherlands B.V., in tranches over two years. Quarterly results were also approved.
- Value
- ₹300.0 Cr
- Execution
- 2 years, in one or more tranches
Great Eastern Shipping Company Capital Structure Change
Great Eastern Shipping bought back 88,877 equity shares on 28 October 2026 at an average of Rs.1,529.71. Total shares bought back under the open-market buyback now stand at 38,48,494.
- Value
- ₹13.60 Cr